FLUm3HA.b-3NA

BASEL, Switzerland, Aug. 31, 2026 XYRA LLC announced that the first patient in Europe has been dosed in the...

TOKYO, Japan and PRINCETON, New Jersey, Aug. 31/Sept. 1, 2026 Kyowa Kirin Co., Ltd. announced a voluntary agreement with...

LONDON, UK, Sept. 1, 2026 GSK announced that it will advance its investigational mRNA seasonal influenza vaccine candidate into...